Edap Tms (EDAP) Competitors $2.53 +0.19 (+7.95%) Closing price 09/19/2025 03:59 PM EasternExtended Trading$2.54 +0.01 (+0.36%) As of 09/19/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EDAP vs. NPCE, DRTS, SKIN, SNWV, SMTI, TCMD, CLPT, BWAY, CATX, and OMShould you be buying Edap Tms stock or one of its competitors? The main competitors of Edap Tms include NeuroPace (NPCE), Alpha Tau Medical (DRTS), Beauty Health (SKIN), Sanuwave Health (SNWV), Sanara MedTech (SMTI), Tactile Systems Technology (TCMD), ClearPoint Neuro (CLPT), Brainsway (BWAY), Perspective Therapeutics (CATX), and Outset Medical (OM). These companies are all part of the "medical equipment" industry. Edap Tms vs. Its Competitors NeuroPace Alpha Tau Medical Beauty Health Sanuwave Health Sanara MedTech Tactile Systems Technology ClearPoint Neuro Brainsway Perspective Therapeutics Outset Medical Edap Tms (NASDAQ:EDAP) and NeuroPace (NASDAQ:NPCE) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends. Is EDAP or NPCE more profitable? NeuroPace has a net margin of -29.29% compared to Edap Tms' net margin of -33.49%. Edap Tms' return on equity of -56.85% beat NeuroPace's return on equity.Company Net Margins Return on Equity Return on Assets Edap Tms-33.49% -56.85% -26.83% NeuroPace -29.29%-168.61%-25.48% Do analysts recommend EDAP or NPCE? Edap Tms currently has a consensus price target of $8.50, indicating a potential upside of 236.50%. NeuroPace has a consensus price target of $16.60, indicating a potential upside of 67.00%. Given Edap Tms' higher possible upside, analysts clearly believe Edap Tms is more favorable than NeuroPace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edap Tms 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33NeuroPace 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Does the media favor EDAP or NPCE? In the previous week, Edap Tms had 3 more articles in the media than NeuroPace. MarketBeat recorded 4 mentions for Edap Tms and 1 mentions for NeuroPace. NeuroPace's average media sentiment score of 1.02 beat Edap Tms' score of 0.82 indicating that NeuroPace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edap Tms 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeuroPace 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation & earnings, EDAP or NPCE? Edap Tms has higher earnings, but lower revenue than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdap Tms$69.18M1.37-$20.58M-$0.61-4.14NeuroPace$88.57M3.71-$27.14M-$0.84-11.83 Which has more volatility and risk, EDAP or NPCE? Edap Tms has a beta of -0.21, meaning that its share price is 121% less volatile than the S&P 500. Comparatively, NeuroPace has a beta of 1.9, meaning that its share price is 90% more volatile than the S&P 500. Do insiders & institutionals believe in EDAP or NPCE? 62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 78.8% of NeuroPace shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by insiders. Comparatively, 20.5% of NeuroPace shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryNeuroPace beats Edap Tms on 10 of the 16 factors compared between the two stocks. Get Edap Tms News Delivered to You Automatically Sign up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EDAP vs. The Competition Export to ExcelMetricEdap TmsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$87.50M$6.76B$5.80B$10.40BDividend YieldN/A1.20%5.63%4.60%P/E Ratio-4.1426.7880.3526.78Price / Sales1.37197.91534.47124.48Price / CashN/A22.0337.9961.55Price / Book2.144.9815.776.40Net Income-$20.58M$178.07M$3.30B$271.80M7 Day Performance3.10%5.36%5.38%3.48%1 Month Performance83.71%10.93%8.10%9.89%1 Year Performance-17.18%17.52%81.54%28.51% Edap Tms Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EDAPEdap Tms2.2592 of 5 stars$2.53+7.9%$8.50+236.5%-17.2%$87.50M$69.18M-4.14230NPCENeuroPace3.154 of 5 stars$9.82-0.4%$16.60+69.0%+34.5%$326.18M$79.91M-11.69170Positive NewsDRTSAlpha Tau Medical1.6113 of 5 stars$3.85+1.0%$9.00+133.8%+66.9%$323.16MN/A-8.0280SKINBeauty Health1.8638 of 5 stars$2.63+4.0%$2.63-0.2%+49.0%$320.87M$334.30M-9.391,030Trending NewsAnalyst ForecastHigh Trading VolumeSNWVSanuwave Health2.4671 of 5 stars$35.57-3.8%$55.00+54.6%N/A$316.85M$32.63M-4.3140Analyst DowngradeSMTISanara MedTech2.0363 of 5 stars$35.01+3.1%$50.00+42.8%-1.2%$302.32M$86.67M-30.1860Positive NewsTCMDTactile Systems Technology2.4619 of 5 stars$13.52+0.1%$13.50-0.1%-1.3%$301.17M$292.98M21.811,037Positive NewsCLPTClearPoint Neuro2.0508 of 5 stars$10.47-0.2%$19.67+87.8%-7.7%$298.20M$31.39M-12.93110BWAYBrainsway3.2096 of 5 stars$15.10-4.2%$18.00+19.2%+88.9%$297.99M$46.08M58.08120Positive NewsCATXPerspective Therapeutics2.0654 of 5 stars$3.59+3.2%$12.56+249.7%-76.4%$266.60MN/A0.0070Positive NewsAnalyst ForecastOMOutset Medical2.212 of 5 stars$13.72+0.2%$24.67+79.8%+59.1%$243.22M$113.69M-0.68520Positive News Related Companies and Tools Related Companies NeuroPace Competitors Alpha Tau Medical Competitors Beauty Health Competitors Sanuwave Health Competitors Sanara MedTech Competitors Tactile Systems Technology Competitors ClearPoint Neuro Competitors Brainsway Competitors Perspective Therapeutics Competitors Outset Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EDAP) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edap Tms S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edap Tms With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
